Scientific Program

Conference Series Ltd invites all the participants across the globe to attend World Congress on Fetal and Maternal Medicine Osaka, Japan .

Day 2 :

Keynote Forum

Dawn M Ireland

CDH International, USA

Keynote: 20 year demographics and preliminary survey results from CDH International

Time : 09:30-10:15 AM

Conference Series Fetal and Maternal Medicine 2018 International Conference Keynote Speaker Dawn M Ireland photo
Biography:

Dawn M Ireland is the Founder of CHERUBS - The Association of Congenital Diaphragmatic Hernia Research, Awareness and Support. She stepped away as President of CHERUBS and into the role of President of CDH International to further the research projects that the organization is involved in. Currently, she oversees CDH International which now runs the world’s largest natural history database of CDH which has 3 boards, employees, many volunteers, assists over 6300 patient families in 70 countries, presents research abstracts and works with both the NIH and the EU. She is also a Founding Member of the Rare Advocacy Movement and senior level patient advocate, mentors several other non-profit organizations, Founding Member of the Alliance of Congenital Diaphragmatic Hernia Organizations, written/edited 4 books and spends her time between the United States and Europe to continue the organization’s growth and outreach.

Abstract:

Purpose: Our objective was to assess the amount of medical information retained by parents of children born with Congenital Diaphragmatic Hernia. Our goal is to review the difference in our study with the population studies of other CDH research groups such as the CDH Study Group and DHREAMS in the amount of information given and correctly retained by CDH parents.

 

Methods: We reviewed the answers provided to a questionnaire between 1995 and 2014. Members included 2547 survivors, 1294 non-survivors and 740 expectant or who did not follow up. Parents were asked basic medical questions as well as a detailed medical and familial history.

 

Results: Our questionnaire was answered by 4548 families. A higher percentage of families of non-surviving infants than surviving infants did not know if their child's CDH occurred on the left versus right side (46.8% vs. 57.8%). When families were asked to further characterize the type of decent their child had, the percentage of those who did not know jumped to approximately 87%, showing that even fewer parents remembered the finer details of their child's diagnosis. Familial CDH is reported in the literature to be known in approximately 2% of all cases. Our membership reports 1.6%, which is similar to what has been reported.

 

Conclusion: Until this study is compared to the studies of DHREAMS and the CDH Study Group and exact patient matching occurs, it is difficult to measure the true medical knowledge that CDH parents grasp and remember.

Keynote Forum

Michael J Sinosich

Sonic Healthcare, Australia

Keynote: State of art in non-invasive prenatal screening

Time : 10:15-11:00 AM

Conference Series Fetal and Maternal Medicine 2018 International Conference Keynote Speaker Michael J Sinosich photo
Biography:

Dr Michael J Sinosich established the Division of Prenatal Testing within Sonic Clinical Institute in 2002. Michael is an internationally respected investigator in early pregnancy well-being. He has published extensively in peer reviewed journals and presented numerous papers at local, national and international forums.

 

Abstract:

 

The urge to procreate has spawned IVF-ART industry and similarly, the desire to know (prenatally) the wellbeing of your unborn child has generated prenatal diagnostic services. Non-Invasive Prenatal Screening (NIPS) includes proteomic, molecular and ultrasonographic testing modalities, applied prenatally to identify a subset of obstetric population assessed to be at increased risk for disorder being screened. Through recent technical advances, quantitation of low abundance DNA has enabled non-invasive prenatal fetal chromosome enumeration. Screening for feto-placental wellbeing, includes ALL current screening modalities: Proteomic (PAPP-A, FbhCG, AFP, PlGF), ultrasonography (NT), extracellular (cf) and intracellular (genomic) DNA. Prior to any definitive intervention, patients with positive screening result should be counseled to seek confirmatory diagnostic testing. Combination of            feto-placental biochemistry with ultrasonographic biometry can provide Trisomy 21 detection rate of 92.9%. Whilst not matching performance of cfDNA (DR=99.9%), clinical application of combine first trimester biochemistry extends beyond screening just for Trisomy 21. Fetal triploidy, which is undetectable by many cfDNA algorithms, presents with median Nuchal Translucency (NT) of 1.35 mm. However, median PAPP-A (0.06 MoM) and FbhCG (0.24 MoM) clearly signal a clinical situation warranting further investigation. Inclusion of PlGF has introduced another dimension to screening because now we can simultaneously screen for fetal and maternal wellbeing, such as, pre-eclampsia. Recent developments allow isolation of fetal-placental cells, which can be applied for chromosome enumeration and for Whole Genome Sequencing (WGS). Cellular targets include Nucleated Fetal Red Blood Cells (NFRBC), Mononucleated Cytotrophoblast (CT) and Polynucleated Syncytiotrophobslast (SCT) cells. After initial enrichment, fetal cell isolation is achieved by laser dissection. Whilst providing a pure fetal cell, this technology is labor intensive and hence, not yet applicable to population based screening. Over the past two decades, non-invasive prenatal screening has progressed from screening for targeted fetal abnormalities to combined prenatal assessment of feto-maternal wellbeing and finally, to prenatal fetal whole genome sequencing.

Keynote Forum

Kai Ye

Xi’an Jiaotong University, China

Keynote: Systematic discovery of complex insertions and deletions in human cancers

Time : 11:15 AM- 12:00 PM

Conference Series Fetal and Maternal Medicine 2018 International Conference Keynote Speaker Kai Ye photo
Biography:

Kai Ye has completed his PhD from Leiden University in the Netherlands and Postdoctoral studies from European Bioinformatics Institute in UK. He has worked as an Assistant Professor at Leiden University Medical Center and Washington University in St. Louis. He has published more than 50 papers in reputed journals.

Abstract:

Complex insertions and deletions (indels) are formed by simultaneously deleting and inserting DNA fragments of different sizes at a common genomic location. Here we present a systematic analysis of somatic complex indels in the coding sequences of samples from over 8,000 cancer cases using Pindel-C. We discovered 285 complex indels in cancer-associated genes (such as PIK3R1TP53ARID1AGATA3 and KMT2D) in approximately 3.5% of cases analyzed; nearly all instances of complex indels were overlooked (81.1%) or misannotated (17.6%) in previous reports of 2,199 samples. In-frame complex indels are enriched in PIK3R1 and EGFR, whereas frameshifts are prevalent in VHLGATA3TP53ARID1APTEN and ATRX. Furthermore, complex indels display strong tissue specificity (such as VHL in kidney cancer samples and GATA3 in breast cancer samples). Finally, structural analyses support findings of previously missed, but potentially druggable, mutations in the EGFRMET and KIT oncogenes. This study indicates the critical importance of improving complex indel discovery and interpretation in medical research.

  • Workshop
Location: Hall- Garden, ANA Crowne Plaza, Osaka

Session Introduction

Adriano Carneiro da Costa

Federal University of Pernambuco, Brazil Sessions: Women Reproductive Health | Maternal-Fetal Medicine | Anesthesia for Fetal

Title: Prognostic value of factors associated with hypoxia and lipid metabolism in patients with colorectal cancer

Time : 12:00-13:00 PM

Speaker
Biography:

Adriano Carnerio  is currently an Oncological Surgeon of the Department of Surgery at the Federal University of Pernambuco, Brazil. He has obtained his Master's degree in Cancer and Oncology Surgery at the A.C. Camargo Cancer Center, Brazil. He is the Fellow of the Department Surgery and Cancer Hammersmith Hospital, Imperial College London 2013.

Abstract:

Background: Colorectal Cancer (CRC) is a neoplasia with high incidence and mortality rates. It had been suggested that the inflammatory response is an important CRC prognostic factor. The disordered and accelerated proliferation of neoplastic cells decreases the oxygen and nutrient supply, generating a microenvironment characterized by hypoxia, necrosis and inflammation.

Aim: This study aimed to evaluate the impact of factors associated with hypoxia, such as HIF1A (Hypoxia-Inducible Factor 1-Alpha) and VEGF (Vascular Endothelial Growth Factor) and with lipid metabolism, including PPARG (Peroxisome Proliferator-Activated Receptor-Gamma), LXRA (Liver X Receptor-Alpha) and LXRB (Liver X Receptor-Beta), on the Overall Survival (OS) of CRC patients.

Methods: This was a cohort study of 101 patients with high-risk stage II-III (TNM) CRC located above the peritoneal reflection. They were treated between 1990 and 2004 at the A.C. Camargo Cancer Center. Immunohistochemical analyses of HIF1A, VEGF, PPARG, LXRA and LXRB protein expression were performed using Tissue Microarrays (TMAs).

Results: There was an association between the presence of vascular invasion and the lack of VEGF expression (p=0.028) as well as with positive HIF1A expression and lymphatic invasion (p=0.045). The 5-year and 10-year OS rates were 76.6% and 60.2%, respectively. Patients with PPARG-positive tumors had a higher OS (p=0.018). There were no correlations between the positive expression of VEGF, HIF1A, LXRA or LXRB and OS. The Cox regression model demonstrated that the risk of death was 2.72-fold higher in patients with PPARG-negative tumors (95% CI=1.08– 6.85).

Conclusion: The PPARG expression was an independent prognostic factor for CRC tumors and might be used for risk stratification to stage II and stage III CRC patients.

  • Women Reproductive Health | Maternal-Fetal Medicine | Anesthesia for Fetal Surgery | Precision Oncology
Location: Hall-Garden, ANA Crowne Plaza Osaka
Speaker

Chair

Dawn M Ireland

CDH International, USA

Session Introduction

Ewa Kurowska

Medicover Hospital, Poland

Title: Dramatic outcome of the delivery as the result of doctor-patient communication insufficiency: Case report

Time : 14:00-14:30 PM

Speaker
Biography:

Ewa Kurowska is an Obstetrics and Gynecology Consultant in Medicover Hospital, Warsaw, Poland. She is the Head Doctor of Obstetrics and Gynecology Department.

 

Abstract:

 

Minimally invasive procedures has become preferable method of treatment because of its indubitable advantages such as less postoperative pain, short hospital stay, fast convalescence and small, invisible scars. But those advantages may become disadvantages with potential dramatic outcome at the same time, because of patients’ impression of light, small and not dangerous procedure which is not worth to be mentioned during medical interview. Frequency of uterine rupture during pregnancy is evaluated at 0.006-0.0125%. It rises during the labor to even 0.06%. The most common risk factor is previous cesarean section or other uterine surgery like myomectomy or hysteroscopic resection. As the first surgery is rather hard to miss, the next two, especially laparoscopic myomectomy can be forgotten by the patient. Because of obstetric and neonatal serious consequences we should pay very close attention to what and how we are asking patients about. We would like to present a case of primigravida, who was admitted to our Department because of short strong abdominal pain ca35 weeks of gestational age. She was in good general condition but because of rupture of the uterus and ablation of the placenta we diagnosed fetal death. Insufficiency of communications between doctor and patient may lead to fetal death and dramatic rescue patient’s procedure. We have to understand that important and obvious situations for doctor are not equal with patient’s priorities. That is why it is necessary to ask specific and simple questions during medical interview to make sure of detailed information.

 

Jan Zivny

Charles University, Czech Republic

Title: Markers of endothelial activation and injury: Influence of the mode of delivery

Time : 14:30-15:00 PM

Speaker
Biography:

Jan Zivny has completed his M.D. in 1993 and Ph.D. in 2000 from First Medical Faculty of Charles University at Prague. He completed postdoctoral fellowship at the University of Alabama at Birmingham School of Medicine and ORISE fellowship at Food and Drug administration (FDA).  He is associate professor at the Institute of Pathological Physiology, First Faculty of Medicine, Charles University at Prague. His work focuses on the biomarkers endothelial activation in health and disease and on pathophysiology of hematological malignancies. He has published more than 40 papers in reputed journals.

                                                                                                                           

Abstract:

Statement of the Problem: Complications during delivery may result in activation and injury of endothelial cells. There is limited information regarding endothelial dysfunction during pregnancy, delivery and in newborns. The purpose of this study was to explore biomarkers of endothelial injury in different modes of delivery and in newborns after delivery.

Method: The study group (Thomayer Hospital Prague, Czech Republic) consisted of mothers and their term healthy newborns after uncomplicated pregnancy and spontaneous delivery (Group A, n=24), after elective cesarean section (Group B, n=12) and after emergency cesarean section (Group C, n=13). Biomarkers were measured in cord blood and in newborns between 48 and 72 hours of life using multiplex immunoassays based Luminex®xMAP multi-analyte profiling platform. Paired t-test and Mann-Whitney test were used for statistical evaluation of the results.

Findings: Significantly higher concentrations of endocan, angiopoietin-2, VEGF and ICAM-1 were found in neonatal samples comparing to cord blood in all three groups (p<0.05). Significant differences were found in cord blood (endocan, angiopoietin-2, VEGF, endothelin-1 and endoglin) when comparing B and C groups (p<0.05).

Conclusion: We found different concentrations of endothelial markers in cord blood compared to neonatal samples. The measured markers according to the mode of delivery showed differences mainly between elective B and acute C cesarean section groups in cord blood. These results show significant changes in concentrations of several potential endothelial dysfunction markers during the first three days following delivery. Concentrations of endothelial markers may be influenced more by complication of pregnancy, e.g. hypoxia leading to acute cesarean section, than by mode of delivery itself.

Biography:

Haniyeh Bashizadeh-Fakhar has completed her PhD from Shahid Beheshti University of Medical Science, Iran. Her studies are on expression proteomics on cancer at Proteomics Research Center. She is working as an Assistant Professor in Azad University. She has published more than 15 papers in reputed journals.

 

Abstract:

Background & Aim: The risks of Ovarian Malignancy Algorithm (ROMA) and Human Epididymis protein 4 (HE4) appear to be the promising predictors of Epithelial Ovarian Cancer (EOC). However, conflicting results have been obtained in the diagnosis process when we compare ROMA, HE4 and CA125.

Method: The databases Medline/PubMed, Embase, Web of Science, Google Scholar, the Cochrane Library and ClinicalTrials.gov and full texts bibliographies were searched for relevant abstracts. EOC predictive value of ROMA was systematically evaluated and the predictive performance of ROMA, HE4 and CA125 were compared within the same population. In this meta-analysis, the pooled sensitivity, pooled speci­ficity, pooled AUC, pooled p-value of each tumor marker as well as pooled number of patients and healthy individuals were calculated.

Result: Based on meta-analysis of 9 studies, the total sample size was obtained, 785 patients and 667 healthy individuals. The overall estimates of ROMA for EOC predicting pre-menopausal women with 95% CI were sensitivity 86.9, specificity 085.52 and 0.9 AUC. ROMA for EOC predicting pre-menopausal women was sensitivity 90, specificity 80.84 and 0.9 AUC. The overall estimates of Ca125 and HE4 for EOC predicting with 95% CI were as follows, sensitivity (84.5 and 80.37), specificity (83.8 and 88.45) and AUC (0.85 and 0.87).

Conclusion: This meta-analysis is highlighted that ROMA can help distinguish EOC from the benign stage in post-menopausal women. ROMA is less specific but more sensitive than HE4. Both ROMA and HE4 are more specific than CA125 for EOC prediction. CA125 has a higher accuracy for diagnosis than HE4 for EOC. ROMA is a good predictor to replace CA125, but its utilization requires further exploration.

Biography:

Julie Sartori has 25 years of experience in Nursing and 5 years as a Research Assistant with projects such as the RAINE Study, Australian Fathers Study and Placenta Project. She has completed her Bachelor’s in Human Biology. She is a valuable member of the Placenta Project, which is instrumental in developing a research framework used to investigate maternal factors that can affect the growth and development of the placenta.

 

Abstract:

The quest to understand human conception and subsequent gestational development has evolved significantly over the past 2000 years. This collective knowledge has now culminated in the reproductive revolution of the 21st century and is crucial to human reproductive development. Current research examining pre and post conception mechanisms, have allowed greater insight into the physiological cascade of events that result in successful pregnancy. These studies also highlight the impact of control mechanisms such as cytoplasmic inheritance and epigenetic regulation on birth outcomes. Human pregnancy is considered viable after three essential processes have occurred, fertilization, implantation and placentation. Preparation for fertilization involves a complex interplay between the maternal pituitary, ovarian and uterine axis. Implantation and placentation results from a complex cascade of events that are orchestrated by fetal, maternal and paternal biochemical signaling. Approximately 75% of unsuccessful pregnancies are lost during the early stages of conceptual development. This is primarily due to inability of the conceptus to attach and implant within the endometrial lining or erroneous modifications during normal trophoblastic differentiation. As part of the placenta project pregnant women from Perth, Western Australia, were recruited from private and public hospitals, with pregnancies resulting from both natural and assisted conceptions. Data will be presented from 630 participants, collected from Maternal Health Questionnaires, gross placental examination and maternal - neonatal medical records. A preliminary examination of current research data has resulted in new information that supports existing reproductive theories and encourages further examination of placental tissue. Using a conceptual approach, maternal factors will be used to highlight the importance of early reproductive mechanisms and the role of the placenta in successful pregnancy, prenatal development and potential long-term health outcome.

 

Biography:

Hisham Al Matubsi has completed his Graduation in Kuwait University in 1986 and postdoctoral studies in Victoria University, Australia in 1997. He is currently the professor of physiology in Al Mareefa College for Science and Technology.

Abstract:

 

To evaluate plasma Kisspeptin-10 (KP-10) and assess its relation to altered reproductive hormones in preeclamptic pregnant women. First time pregnant women n=100 at 20 weeks of gestation participated in this study and divided into pre eclamptics n=60 and normotensives n=40. KP-10, Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH), beta-Human Chorionic Gonadotropin (β-HCG), Estradiol (E2) and Progesterone (PRG) were evaluated during second and third trimesters of pregnancy for all women. Kisspeptin-10 levels were reduced in PE women compared with normotensive pregnancies. In 2nd trimester, area under Receiver-Operator Characteristic (ROC) curve was 0.662, positive and negative predictive values were 32.8 and 94.6 and test sensitivity and specificity were 55% and 87.5%, respectively. In the 3rd trimester, area under ROC curve was 0.747 positive and negative predictive values were 22.2 and 97.3 and test sensitivity and specificity were 83.3% and 67.5%, respectively. In PE patients, plasma KP-10 demonstrated inverse correlation with E2 (during the 2nd trimester), LH and FSH (during the 3rd trimester) and positively correlated with β-HCG (during the 3rd trimester). Relatively high KP-10 sensitivity with the largest area under the ROC curves during 2nd and 3rd trimester of pregnancy, suggesting that is statistically acceptable as a diagnostic screening tool to rule out the PE especially in 3rd trimester.

Biography:

Mohammed Ashraf Puthiyachirakkal has completed his Medical School and Pediatric Residency from India. He has completed his Pediatric Residency from Brookdale hospital New York and Neonatal fellowship from Metrohealth Medical Center, Cleveland, Ohio and worked as Attending Neonatologist in Mercy St Vincent Medical center, Toledo. He also worked as Consultant Pediatrician and Neonatologist in Al Zahra Hospital Sharjah.

Abstract:

Human being harbors 100 trillions of microbes in the gastrointestinal tract, which is very diverse and dynamic. The microbiota starts to develop even in the fetal state and continue to develop to reach the adult level by 2-3 years of life. There are various factors involved in the colonization of these bacteria. These microbiota have role in the metabolism, immunologic development, epigenetic effects, act as energy sources, help in synthesis of vitamins, amino acid, have antimicrobial properties and detoxification effects. Alteration in the microbiota, dysbiosis is believed to be responsible for the development of allergic diseases, late onset sepsis, NEC, obesity and Type 1 diabetes. It is very crucial to understand the colonization process and the factors modulating the microbiota so that we can prevent the intestinal dysbiosis and future developments of the physical and behavioral problems.